Skip to content
America's Blood Centers
  • About
    • About ABC
    • Leadership
    • Committees
    • ABC Strategic Plan
    • Partners
    • Careers
    • Membership Directory
    • Foundation
    • ADRP
  • Advocacy
    • 2023 Advocacy Agenda
    • Our Priorities
      • Strengthening the Blood Supply
      • Expanding Access to Blood Products
      • Moving Toward an Individual Donor Assessment
      • Diversifying the Donor Base
      • Eliminating Unnecessary and Duplicative Testing Requirements
      • Lowering the U.S. Platelet Content Requirement
      • Updating vCJD Guidance
      • Expanding the Availability of Blood in Hospice
    • Letters and Comments
  • Events
    • 2023 Day on Capitol Hill
    • Blood Advocacy Week
    • 2023 MD Workshop & Summer Summit
    • 2023 Awards of Excellence
    • ADRP Annual Conference
    • All Upcoming Events
    • Sponsors
      • Sponsorship Opportunities
  • News
    • Latest News
    • Press Releases
    • For Media
  • Publications
    • ABC Newsletter
    • Blood Bulletin
    • Grassroots Handbook
    • U.S. Blood Donation Statistics and Public Messaging Guide
    • Vein to Vein: The Science of Blood Donation
    • Blood Centers Career Video
    • ABC Benchmark Surveys
    • The Value of Blood
    • Advertise
    • Grant Funding Guide 🔒
  • For Members
    • CollABOrate🔒
    • Recent Member Communications (MCNs)🔒
    • Talking Points🔒
    • Member Snapshot Survey Reports🔒
    • ABC Newsletter Archive🔒
    • Webinar Recordings🔒
      • Advocacy Webinars🔒
      • Donor Management Webinars🔒
      • Human Resources Webinars🔒
      • SMT Journal Club Webinars🔒
      • Quality Education Webinars🔒
    • Resources
    • Get Involved
    • Directory
  • For Donors
    • About Donation
    • Journey of Blood
    • Find a Blood Center
    • DonatingBlood.org
    • Current U.S. Blood Supply
  • HOSA Partners
  • Member Login
America's Blood Centers
  • About
    • About ABC
    • Leadership
    • Committees
    • ABC Strategic Plan
    • Partners
    • Careers
    • Membership Directory
    • Foundation
    • ADRP
  • Advocacy
    • 2023 Advocacy Agenda
    • Our Priorities
      • Strengthening the Blood Supply
      • Expanding Access to Blood Products
      • Moving Toward an Individual Donor Assessment
      • Diversifying the Donor Base
      • Eliminating Unnecessary and Duplicative Testing Requirements
      • Lowering the U.S. Platelet Content Requirement
      • Updating vCJD Guidance
      • Expanding the Availability of Blood in Hospice
    • Letters and Comments
  • Events
    • 2023 Day on Capitol Hill
    • Blood Advocacy Week
    • 2023 MD Workshop & Summer Summit
    • 2023 Awards of Excellence
    • ADRP Annual Conference
    • All Upcoming Events
    • Sponsors
      • Sponsorship Opportunities
  • News
    • Latest News
    • Press Releases
    • For Media
  • Publications
    • ABC Newsletter
    • Blood Bulletin
    • Grassroots Handbook
    • U.S. Blood Donation Statistics and Public Messaging Guide
    • Vein to Vein: The Science of Blood Donation
    • Blood Centers Career Video
    • ABC Benchmark Surveys
    • The Value of Blood
    • Advertise
    • Grant Funding Guide 🔒
  • For Members
    • CollABOrate🔒
    • Recent Member Communications (MCNs)🔒
    • Talking Points🔒
    • Member Snapshot Survey Reports🔒
    • ABC Newsletter Archive🔒
    • Webinar Recordings🔒
      • Advocacy Webinars🔒
      • Donor Management Webinars🔒
      • Human Resources Webinars🔒
      • SMT Journal Club Webinars🔒
      • Quality Education Webinars🔒
    • Resources
    • Get Involved
    • Directory
  • For Donors
    • About Donation
    • Journey of Blood
    • Find a Blood Center
    • DonatingBlood.org
    • Current U.S. Blood Supply
March 24, 2023

Inclusive Donor Eligibility Criteria Supported in Comments to FDA

By America's Blood Centers

America’s Blood Centers (ABC), the Association for the Advancement of Blood & Biotherapies (AABB), and the American Red Cross submitted joint comments to the U.S. Food and Drug Administration’s (FDA) guidance titled “Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry” supporting a shift to more inclusive donor eligibility criteria. In the comments, the blood community expressed their support for “evidence-based decision-making to update donor eligibility requirements” also requesting that the agency replace individual risk assessment with individual donor assessment in the final guidance “to remove the negative connotation perceived by donors and the public.”

The comments urged the agency to address donor use of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), and antiretroviral therapies (ART) by requesting that “federal government partners join FDA in protecting the safety of the blood supply by actively promoting consistent messaging at every opportunity to the public.” The blood community also advocated for timely evaluation of evidence-based decisions to update requirements for blood products to determine where similar updates can be appropriately applied to requirements for biotherapy products.”

Additionally, the blood community asked the agency to assist with messaging on implementation timelines by “establish[ing] public messaging noting FDA’s landmark decision and emphasizing our collective commitment to sustaining the high level of safety for our blood supply.” In particular, communicating landmark changes, such as those proposed by FDA, must “be implemented with a commitment to safety over speed to maintain the public’s trust in the blood supply [and] require extensive staff training and education, [along with] patience and public support for blood donor centers supplying transfusion services to meet the needs of patients across the country.”

The blood community also requested that implementation “recognize the challenges and extended implementation timelines based on the collection of plasma for further manufacture.”

The comments also provided:

  • recommendations on “clarification [of the] reference to ‘positive test’ verses ‘confirmed positive test;’”
  • recommendations on clarification of “sexual contact with a person who has ‘ever had a positive test for HIV’ versus a ‘confirmed positive test for HIV;’”
  • recommendations on the “definition of a ‘new partner;’” and
  • recommendations on “calculating the donor deferral period.”

The blood community concluded the comments by recognizing the FDA’s “commitment to evidence-based donor eligibility recommendations to support the safety and availability of the blood supply” and expressing gratitude for the agency’s willingness to “work with us as we review the published data supporting the recommendations in the final guidance and prepare for the complex implementation process which will follow.”

View the Full Comments.
Posted in Letters and Comments
Share this

Recent Posts

  • FDA Finalizes Shift to Individual Donor Assessments
  • Blood Community Applauds Important Step Forward for Blood Donor Eligibility
  • America’s Blood Centers Supports Final FDA Guidance Implementing Individual Blood Donor Assessments
  • ADRP Announces Rebranding, Becomes The Association for Blood Donor Professionals
  • Blood Advocacy Week Draws More Than 400 Participants

Categories

  • ABC Newsletter
  • Blood Bulletin
  • Letters and Comments
  • News
  • Press Releases
  • Statements

Contact

abc-60-logo

1717 K Street NW, Suite 900
Washington, DC 20006

Tel: 202-393-5725

Fax: 202-899-2621

  • About
    • About ABC
    • Leadership
    • Committees
    • ABC Strategic Plan
    • Partners
    • Careers
    • Membership Directory
    • Foundation
    • ADRP
  • Advocacy
    • 2023 Advocacy Agenda
    • Our Priorities
      • Strengthening the Blood Supply
      • Expanding Access to Blood Products
      • Moving Toward an Individual Donor Assessment
      • Diversifying the Donor Base
      • Eliminating Unnecessary and Duplicative Testing Requirements
      • Lowering the U.S. Platelet Content Requirement
      • Updating vCJD Guidance
      • Expanding the Availability of Blood in Hospice
    • Letters and Comments
  • Events
    • 2023 Day on Capitol Hill
    • Blood Advocacy Week
    • 2023 MD Workshop & Summer Summit
    • 2023 Awards of Excellence
    • ADRP Annual Conference
    • All Upcoming Events
    • Sponsors
      • Sponsorship Opportunities
  • News
    • Latest News
    • Press Releases
    • For Media
  • Publications
    • ABC Newsletter
    • Blood Bulletin
    • Grassroots Handbook
    • U.S. Blood Donation Statistics and Public Messaging Guide
    • Vein to Vein: The Science of Blood Donation
    • Blood Centers Career Video
    • ABC Benchmark Surveys
    • The Value of Blood
    • Advertise
    • Grant Funding Guide 🔒
  • For Members
    • CollABOrate🔒
    • Recent Member Communications (MCNs)🔒
    • Talking Points🔒
    • Member Snapshot Survey Reports🔒
    • ABC Newsletter Archive🔒
    • Webinar Recordings🔒
      • Advocacy Webinars🔒
      • Donor Management Webinars🔒
      • Human Resources Webinars🔒
      • SMT Journal Club Webinars🔒
      • Quality Education Webinars🔒
    • Resources
    • Get Involved
    • Directory
  • For Donors
    • About Donation
    • Journey of Blood
    • Find a Blood Center
    • DonatingBlood.org
    • Current U.S. Blood Supply
  • Sitemap
  • Privacy Policy
  • Terms of Use
Become a Member
Member Login

Copyright © 2023 © America's Blood Centers. All Rights Reserved.

Website by Yoko Co

Scroll To Top